EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Complement as a Biomarker for Systemic Lupus Erythematosus

Masahiro Ayano, Takahiko Horiuchi

Biomolecules · 15.02.2023 · 13 (2) · 367

DOI: 10.3390/biom13020367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 15.02.2023. Verfasst von Masahiro Ayano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582,…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a disease of immune complex deposition; therefore, complement plays a vital role in the pathogenesis of SLE. In general, complement levels in blood and complement deposition in histological tests are used for the management of SLE. Thus, the evaluation of complement status can be useful in the diagnosis of SLE, assessment of disease activity, and prediction of treatment response and prognosis. In addition, novel complement biomarkers, such as split products and cell-bound complement activation products, are considered to be more sensitive than traditional complement markers, such as serum C3 and C4 levels and total complement activity (CH50), which become more widely used. In this review, we report the complement testing in the management of SLE over the last decade and summarize their utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansComplement System ProteinsBiomarkers

Stichwörter der Autor:innen

cell-bound complement activation productcomplementlupus nephritisserological activitysplit productsystemic lupus erythematosus

Substanzen

Complement System ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Cancer Stem Cell Research, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Internal Medicine, Kyushu University Beppu Hospital, 4546 Tsurumibaru, Tsurumi, Beppu 874-0838, Japan.

Zitieren

APA

Ayano, M., & Horiuchi, T. (2023). Complement as a Biomarker for Systemic Lupus Erythematosus. Biomolecules, 13(2), 367. https://doi.org/10.3390/biom13020367

Vancouver

Ayano M, Horiuchi T. Complement as a Biomarker for Systemic Lupus Erythematosus. Biomolecules. 2023;13(2):367. doi:10.3390/biom13020367

BibTeX
@article{Ayano2023,
  author = {Ayano, Masahiro and Horiuchi, Takahiko},
  title = {Complement as a Biomarker for Systemic Lupus Erythematosus},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {367},
  doi = {10.3390/biom13020367}
}
Kostenlos starten →